Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
ERBB family receptor tyrosine kinases are overexpressed in a significant subset of breast cancers. One of these receptors, HER2/neu, or ErbB-2, is the target for a new rational therapeutic antibody, Herceptin. Other inhibitors that target this receptor, and another family member, the epidermal growt...
Tallennettuna:
| Julkaisussa: | Breast Cancer Res |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2000
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138772/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11250707/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr51 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|